- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03560297
SeRenade Parent-Child Music Class Program
February 5, 2022 updated by: Miriam Lense, Vanderbilt University Medical Center
SeRenade Parent-Child Music Class Program for Families of Children With and Without ASD
This pilot study examines the impact of the SeRenade Parent-Child Music Class Program, which emphasizes parent training, peer inclusion, and musical play combined with established behavioral techniques, on the development of child social engagement, positive behavior, and parental well-being.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This pilot study evaluates the impact of the SeRenade Parent-Child Music Class Program on families of children with and without autism spectrum disorders (ASD).
This study examines the impact of this program on social development in children with ASD, parental stress and efficacy, and parent-child relationships.
A primary goal of this study is to examine multiple levels of analysis including families' experience within and outside of the music class program.
Study Type
Interventional
Enrollment (Actual)
70
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 6 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- children diagnosed with ASD or children without ASD
Exclusion Criteria:
- currently enrolled in music therapy or parent-child music classes (for children with ASD); significant behavior problems (e.g., aggression toward other children); significant hearing or visual impairments
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: SeRenade Program
Parent-Child Music Class Program (parent training, peer inclusion, musical play)
|
Parent-Child Music Class involving parent training, peer inclusion, and musical play
|
|
EXPERIMENTAL: Delayed/Waitlist Program
Participants do not participate in the program for a time period
|
Participants receive intervention after delay
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Motor Imitation Scale
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
Standardized elicited imitation assessment; scores range 0-32; greater scores indicate greater imitation skills
|
Change from pre to post program (baseline and 12-weeks)
|
|
Actions & Gestures
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
Standardized parent report questionnaire of child's gestures/actions/pretend play
|
Change from pre to post program (baseline and 12-weeks)
|
|
Parenting Stress Index, 4th edition Short Form
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
Standardized parent report questionnaire
|
Change from pre to post program (baseline and 12-weeks)
|
|
Parenting Efficacy/Quality
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
Parent report questionnaire; higher scores indicate greater efficacy, range 10-40
|
Change from pre to post program (baseline and 12-weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parent-Child Interaction
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
parent-child play/music session
|
Change from pre to post program (baseline and 12-weeks)
|
|
social visual attention eye-tracking paradigm
Time Frame: Change from pre to post program (baseline and 12-weeks)
|
Change from pre to post program (baseline and 12-weeks)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
parent mood/connection
Time Frame: change from before/after the class session at class 1 (week 1) to 12 (week 12) (a session of classes is 12-weeks on average)
|
parent ratings
|
change from before/after the class session at class 1 (week 1) to 12 (week 12) (a session of classes is 12-weeks on average)
|
|
Program acceptability
Time Frame: post program (12 weeks)
|
parent program evaluation survey
|
post program (12 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 15, 2018
Primary Completion (ACTUAL)
December 23, 2019
Study Completion (ACTUAL)
March 20, 2020
Study Registration Dates
First Submitted
May 21, 2018
First Submitted That Met QC Criteria
June 15, 2018
First Posted (ACTUAL)
June 18, 2018
Study Record Updates
Last Update Posted (ACTUAL)
February 8, 2022
Last Update Submitted That Met QC Criteria
February 5, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Autism Spectrum Disorder
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Anticonvulsants
- Nitrazepam
Other Study ID Numbers
- 160784
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Deidentified data and codebooks will be available to researchers upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.